News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website


FDA approves Afinitor for brain tumor treatment


Posted on: 10/30/2010

UPDATE 1-FDA approves Afinitor for brain tumor treatment



Novartis AG
12:00am EDT

NEW YORK | Fri Oct 29, 2010 11:10pm EDT

Oct 29 (Reuters) - The Food and Drug Administration has approved Novartis AG's (NOVN.VX) Afinitor to treat benign brain tumors, Novartis said on Friday.

The drug can be used to treat adults and children with benign brain tumors associated with tuberous sclerosis, a genetic disorder that may cause tumors to form in vital organs.

Prior to the approval, the only option to treat this form of tumor was surgery, according to Novartis.

The approval was based on a 28-patient study which showed that nearly one-third of patients had at least a 50 percent reduction in their largest tumors after six months.


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557